Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma

Original Article

A. Perrot, J. Lambert, C. Hulin, A. Pieragostini, L. Karlin, B. Arnulf, P. Rey, L. Garderet, M. Macro, M. Escoffre-Barbe, J. Gay, T. Chalopin, R. Gounot, J.-M. Schiano, M. Mohty, X. Leleu, S. Manier, C. Mariette, C. Chaleteix, T. Braun, B.D. Prijck, H. Avet-Loiseau, J.-Y. Mary, J. Corre, P. Moreau, and C. Touzeau

N Engl J Med 2025;393:425-437

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
07/30/2025
Course expires: 
07/31/2027

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.